Pulmicort Turbuhaler Innöndunarduft 400 míkróg/skammt איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort turbuhaler innöndunarduft 400 míkróg/skammt

astrazeneca a/s - budesonidum inn - innöndunarduft - 400 míkróg/skammt

Pulmicort Turbuhaler Innöndunarduft 100 míkróg/skammt איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort turbuhaler innöndunarduft 100 míkróg/skammt

astrazeneca a/s - budesonidum inn - innöndunarduft - 100 míkróg/skammt

Pulmicort Turbuhaler Innöndunarduft 200 míkróg/skammt איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort turbuhaler innöndunarduft 200 míkróg/skammt

astrazeneca a/s - budesonidum inn - innöndunarduft - 200 míkróg/skammt

Pulmicort Dreifa í eimgjafa 0,125 mg/ml איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,125 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,125 mg/ml

Pulmicort Dreifa í eimgjafa 0,25 mg/ml איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,25 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,25 mg/ml

Pulmicort Dreifa í eimgjafa 0,5 mg/ml איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,5 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,5 mg/ml

Trevicta (previously Paliperidone Janssen) האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

trevicta (previously paliperidone janssen)

janssen-cilag international nv - paliperidon palmitat - geðklofa - psycholeptics - trevicta, 3 mánaða innspýting, er ætlað til viðhaldsmeðferðar við geðklofa hjá fullorðnum sjúklingum sem eru klínískt stöðugar á 1 mánaðar meðferð með paliperidon palmitati.

Byannli (previously Paliperidone Janssen-Cilag International) האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidon palmitat - geðklofa - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Xeplion האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

xeplion

janssen-cilag international n.v. - paliperidon palmitat - geðklofa - psycholeptics - xeplion er ætlað til viðhaldsmeðferðar við geðklofa hjá fullorðnum sjúklingum sem eru stöðugir með paliperidoni eða risperidoni. in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.

Cernevit Stungulyfsstofn, lausn איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

cernevit stungulyfsstofn, lausn

baxter medical ab* - vítamín a (palmítat); colecalciferolum inn; vítamín e (tocoferolum nfn); acidum ascorbicum inn; thiaminum cocarboxylase tetrahýdrat; riboflavinum natríumfosfat díhýdrat; pyridoxinum hýdróklóríð; cyanocobalaminum inn; acidum folicum inn; dexpanthenolum inn; biotinum inn; nicotinamidum inn - stungulyfsstofn, lausn